Principal Financial Group Inc. Trims Stock Position in Addus HomeCare Corporation $ADUS

Principal Financial Group Inc. cut its stake in Addus HomeCare Corporation (NASDAQ:ADUS) by 1.8% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 434,471 shares of the company’s stock after selling 7,891 shares during the quarter. Principal Financial Group Inc.’s holdings in Addus HomeCare were worth $40,688,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Royal Bank of Canada increased its position in shares of Addus HomeCare by 24.3% during the first quarter. Royal Bank of Canada now owns 6,899 shares of the company’s stock valued at $682,000 after buying an additional 1,347 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Addus HomeCare by 4.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,374 shares of the company’s stock worth $1,026,000 after buying an additional 459 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in Addus HomeCare by 6.1% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 51,679 shares of the company’s stock worth $5,111,000 after buying an additional 2,952 shares during the period. Jane Street Group LLC boosted its position in Addus HomeCare by 387.6% during the 1st quarter. Jane Street Group LLC now owns 11,045 shares of the company’s stock valued at $1,092,000 after acquiring an additional 8,780 shares in the last quarter. Finally, Intech Investment Management LLC grew its holdings in shares of Addus HomeCare by 44.7% during the 1st quarter. Intech Investment Management LLC now owns 14,362 shares of the company’s stock worth $1,420,000 after acquiring an additional 4,439 shares during the period. 95.35% of the stock is owned by hedge funds and other institutional investors.

Addus HomeCare Trading Up 0.6%

NASDAQ:ADUS opened at $114.52 on Friday. The firm has a market capitalization of $2.14 billion, a P/E ratio of 21.17, a PEG ratio of 1.57 and a beta of 0.88. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.83 and a quick ratio of 1.83. Addus HomeCare Corporation has a one year low of $87.95 and a one year high of $124.43. The company’s 50-day simple moving average is $97.48 and its 200 day simple moving average is $101.10.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, May 4th. The company reported $1.62 earnings per share for the quarter, beating analysts’ consensus estimates of $1.52 by $0.10. Addus HomeCare had a net margin of 6.89% and a return on equity of 9.80%. The business had revenue of $363.50 million during the quarter, compared to the consensus estimate of $366.41 million. During the same quarter last year, the firm earned $1.42 earnings per share. The business’s revenue for the quarter was up 7.7% on a year-over-year basis. As a group, analysts forecast that Addus HomeCare Corporation will post 6.24 EPS for the current fiscal year.

Insider Buying and Selling at Addus HomeCare

In related news, insider Heather Brianne Dixon sold 288 shares of the company’s stock in a transaction that occurred on Monday, June 22nd. The stock was sold at an average price of $93.77, for a total value of $27,005.76. Following the sale, the insider owned 44,371 shares in the company, valued at $4,160,668.67. This represents a 0.64% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 966 shares of company stock valued at $90,168. Corporate insiders own 4.10% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on ADUS. Citizens Jmp reissued a “market outperform” rating and issued a $142.00 target price on shares of Addus HomeCare in a research report on Monday, May 18th. Weiss Ratings upgraded Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 9th. Wall Street Zen cut Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, March 21st. Finally, Barclays increased their price objective on Addus HomeCare from $92.00 to $96.00 and gave the stock an “underweight” rating in a report on Wednesday, July 8th. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $131.50.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.